Diagnostic value of anti-cyclic citrullinated peptide antibodies in northern Chinese Han patients with rheumatoid arthritis and its correlation with disease activity

Clinical Rheumatology

Volumn 29, Issue 4, 2010, Pages 413-417

  Hui, Li ^a   Wuqi, Song ^a   Yang, Li ^a   Yanhong, Liu ^a   Jing, Bai ^a   Xiu, Li ^a   Fengyun, Mu ^a   Yao, Wang ^a   Fengshan, Zhang ^a   Liju, Su ^a   Fengmin, Zhang ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Anti cyclic citrullinated peptide antibodies; Disease activity; Rheumatoid arthritis; Rheumatoid factor

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY; RHEUMATOID FACTOR;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CHINESE; CLINICAL TRIAL; COMPUTER PROGRAM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ACTIVITY; DISEASE DURATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORNING STIFFNESS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY;

ADULT; ANTIBODIES; ARTHRITIS, RHEUMATOID; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHINA; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; PEPTIDES, CYCLIC;

EID: 77950863633     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-009-1337-2     Document Type: Article

References (14)

1. R Mediwake DA Isenberg GA Schellekens, et al. 2001 Use of anti-citrullinated peptide and anti-RA33 antibodies in distinguishing erosive arthritis in patients with systemic lupus erythematosus and rheumatoid arthritis Ann Rheum Dis 60 67 68 10.1136/ard.60.1.67 1:CAS:528:DC%2BD3MXhslGgtLw%3D 11114286 (Pubitemid 32038957)
2. IG Silveira RW Burlingame CA von Mühlen, et al. 2007 Anti-CCP antibodies have more diagnostic impact than rheumatoid factor (RF) in a population tested for RF Clin Rheumatol 26 1883 1889 10.1007/s10067-007-0601-6 1:STN:280:DC%2BD2srnvFemsg%3D%3D 17410320 (Pubitemid 47516969)
3. M Bukhari W Thomson H Naseem, et al. 2007 The performance of anti-cyclic citrullinated peptide antibodies in predicting the severity of radiologic damage in inflammatory polyarthritis: results from the Norfolk Arthritis Register Arthritis Rheum 56 2929 2935 10.1002/art.22868 1:STN:280:DC%2BD2srnt1Cqtw%3D%3D 17763407 (Pubitemid 47502739)
4. CL Yang YR Zhou F Zhou, et al. 2007 Diagnostic value of serum anti-cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis Nan Fang Yi Ke Da Xue Xue Bao 27 1277 1279 1:CAS:528:DC%2BD2sXhtVynu7%2FM 17715048
5. X Zeng M Ai X Tian, et al. 2003 Diagnostic value of anti-cyclic citrullinated peptide antibody in patients with rheumatoid arthritis J Rheumatol 30 1451 1455 1:CAS:528:DC%2BD3sXmtFSqs7c%3D 12858440 (Pubitemid 36835438)
6. Y Wu Y Xu Y Sun, et al. 2008 Association between the serotonin 1A receptor C(-1019)G polymorphism and major depressive disorder in the northern Han ethnic group in China Chin Med J 121 874 876 1:CAS:528:DC%2BD1cXnslGqsbY%3D 18706198
7. DAS-Score.NL. [ http://www.das-score.nl/www.das-score.nl/index.html ]
8. T Mimori 2005 Clinical significance of anti-CCP antibodies in rheumatoid arthritis Intern Med 44 1112 1126 10.2169/internalmedicine.44.1122
9. JS Kwok KH Hui TL Lee, et al. 2005 Anti-cyclic citrullinated peptide: diagnostic and prognostic values in juvenile idiopathic arthritis and rheumatoid arthritis in a Chinese population Scand J Rheumatol 34 359 366 10.1080/03009740510026634 1:CAS:528:DC%2BD2MXht1GhtL3O 16234183 (Pubitemid 41545908)
10. T Barnetche A Constantin A Cantagrel, et al. 2008 New classification of HLA-DRB1 alleles in rheumatoid arthritis susceptibility: a combined analysis of worldwide samples Arthritis Res Ther 10 R26 10.1186/ar2379 18307784 (Pubitemid 351420395)
11. I Senkpiehl M Marget M Wedler, et al. 2005 HLA-DRB1 and anti-cyclic citrullinated peptide antibody production in rheumatoid arthritis Int Arch Allergy Immunol 137 315 318 10.1159/000086463 1:CAS:528:DC%2BD2MXnvFyntLk%3D 15970640 (Pubitemid 41161023)
12. FA van Gaalen J van Aken TWJ Huizinga, et al. 2004 Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influence the severity of rheumatoid arthritis Arthritis Rheum 50 2113 2121 10.1002/art.20316 15248208 (Pubitemid 38924388)
13. LY Fan M Zong TB Lu, et al. 2009 Association of the PADI4 gene polymorphism and HLA-DRB1 shared epitope alleles with rheumatoid arthritis Zhong hua Yi Xue Yi Chuan Xue Za Zhi 26 57 61 1:CAS:528:DC%2BD1MXhtlemt7fJ
14. Y Xue J Zhang YM Chen, et al. 2008 The HLA-DRB1 shared epitope is not associated with antibodies against cyclic citrullinated peptide in Chinese patients with rheumatoid arthritis Scand J Rheumatol 37 183 187 10.1080/03009740701874444 1:CAS:528:DC%2BD1cXnsVyqsLY%3D 18465452 (Pubitemid 351874005)